Cargando…
Exosomal cancer immunotherapy is independent of MHC molecules on exosomes
Peptide-loaded exosomes are promising cancer treatment vehicles; however, moderate T cell responses in human clinical trials indicate a need to further understand exosome-induced immunity. We previously demonstrated that antigen-loaded exosomes carry whole protein antigens and require B cells for in...
Autores principales: | Hiltbrunner, Stefanie, Larssen, Pia, Eldh, Maria, Martinez-Bravo, Maria-Jose, Wagner, Arnika K., Karlsson, Mikael C.I., Gabrielsson, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122422/ https://www.ncbi.nlm.nih.gov/pubmed/27231849 http://dx.doi.org/10.18632/oncotarget.9585 |
Ejemplares similares
-
Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour
por: Eldh, Maria, et al.
Publicado: (2021) -
Potentiating antitumor immunity with αGC-loaded exosomes
por: Gehrmann, Ulf, et al.
Publicado: (2013) -
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity
por: Wagner, Arnika K., et al.
Publicado: (2021) -
Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging
por: Hiltbrunner, Stefanie, et al.
Publicado: (2020) -
Breast Milk and Solid Food Shaping Intestinal Immunity
por: Parigi, Sara M., et al.
Publicado: (2015)